logo
Colin Farrell looks smart in a navy blue suit as he films for season two of Apple TV series Sugar in Los Angeles

Colin Farrell looks smart in a navy blue suit as he films for season two of Apple TV series Sugar in Los Angeles

Daily Mail​a day ago

Colin Farrell looked smart as he filmed scenes for season two of his Apple TV series Sugar in Los Angeles on Friday.
The Irish actor, 48, who stars as lead character John Sugar in the neo-noir mystery drama, wore a navy blue suit as he got in character.
He completed his look with a black tie and added a pair of brown leather dress shoes.
Colin shielded his eyes with a pair of square-framed sunglasses and was seen chatting with other members of the cast.
The series follows private investigator John as he investigates the disappearance of a wealthy movie producer's granddaughter.
From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new Showbiz newsletter to stay in the loop.
It comes after Colin revealed the reason behind his decision to place his adult disabled son into care - explaining that he wants to ensure his son's care is properly managed while he and his ex-partner are still alive, and to provide him with a strong sense of community.
The actor previously explained how son James, 21, was heartbreakingly misdiagnosed with cerebral palsy before doctors eventually confirmed he was suffering from Angelman syndrome.
Angelman syndrome, a rare genetic disorder that primarily affects the nervous system, causes severe physical and intellectual disability.
Speaking to Candis Magazine, Colin revealed he and his ex Kim Bordenave have made a decision and plan to settle James into a long-term care facility.
He said: 'It's tricky, some parents will say: "I want to take care of my child myself." And I respect that.
'But my horror would be... What if I have a heart attack tomorrow, and, God forbid, James' mother, Kim, has a car crash and she's taken too – and then James is on his own?
'Then he's a ward of the state and he goes where? We'd have no say in it.'
He and Kim are hoping to 'find somewhere we like where he can go now, while we're still alive and healthy, that we can go and visit, and we can take him out sometimes'.
Colin continued: 'We want him to find somewhere where he can have a full and happy life, where he feels connected.'
WHAT IS CEREBRAL PALSY?
Cerebral palsy is the name for a set of conditions affecting movement and co-ordination stemming from a problem with the brain that takes place before, during or soon after birth.
Symptoms are not typically obvious immediately after a child is born — but instead normally become noticeable after two or three years.
They include delays in reaching development milestones, such as:
not sitting by eight months;
not walking by 18 months;
appearing too stiff or too floppy;
walking on tip-toes;
weak arms or legs;
fidgety, jerky or clumsy movements;
random, uncontrolled movements;
Difficulty speaking, swallowing or seeing — along with learning difficulties — can also be symptoms.
Cerebral palsy symptoms can be caused by a number of things and are not necessarily an indication of the condition, which can occur if a child's brain does not develop normally while in the womb, or is damaged during or soon after birth.
Causes include bleeding in the baby's brain, reduced blood and oxygen supply, infection caught by the mother while pregnant, asphyxiation during a difficult birth, meningitis or a serious head injury - though the precise cause is often not clear.
There is no cure currently, but physiotherapy, speech therapy, occupational therapy and medication are often used as treatment.
Each person living with the condition is affected in a different way, but generally speaking most children live into adult life and some can live for many decades.
The Phone Booth actor previously discussed his first-born son's condition and said medical advice was sought after James missed developmental milestones and struggled to sit up or crawl as a baby.
Colin explained how many sufferers of the rare syndrome are often misdiagnosed with cerebral palsy due to both conditions having similar symptoms.
He told People: '[James] couldn't sit up. He wasn't crawling. I think he was a year and a half when we took him to get really checked out, and he was diagnosed as having cerebral palsy.'
Cerebral palsy is the name for a set of conditions affecting movement and co-ordination stemming from a problem with the brain that takes place before, during or soon after birth.
Difficulty speaking, swallowing or seeing — along with learning difficulties — can also be symptoms.
Colin said: 'It was a common misdiagnosis, because it shared a lot of the same characteristics. And that was a downer for sure.'
The Oscar nominee revealed that, when James was only about two and a half years old, a pediatric neurologist suggested he be tested for Angelman syndrome.
Recalling the moment he received the diagnosis, he shared: 'I remember the first two questions I asked were, "What's the life expectancy and how much pain is involved?"
'And the doctor said, "Life expectancy, as far as we can tell, is the same for you and for me, and pain, no."'
A doctor had noticed an unusual symptom that prompted him to test for Angelman syndrome.
Colin explained: 'One of the characteristics of Angelman syndrome is outbreaks of laughter. And the doctor saw that James was laughing a lot and doing this movement [he waves his hands],' the father-of-two shared.
Angelman syndrome is also characterized by seizures, which Colin - who also shares son Henry Tadeusz, 15, with Polish actress Alicja Bachleda-Curus, 41 - said is 'one of the things that parents struggle with greatly'.
He added: 'Thankfully, James hasn't had a breakthrough seizure now in about 10 or 11 years, but I've been in the back of ambulances, I've been in the hospital with him.
'I've done Diastat [a sedative] up his rectum to get him out of a seizure that lasted longer than three minutes. Finding the right amount of medication that doesn't have adverse effects — that's all very tricky business.'
The actor is now launching the Colin Farrell Foundation to provide support, education, and advocacy for adults with intellectual disabilities.
'This is the first time I've spoken about it, and obviously the only reason I'm speaking is I can't ask James if he wants to do this,' he said.
The proud dad stated that his eldest son 'has worked so hard all his life, so hard'.
He said: 'Repetition, repetition, balance, his jerky gait. When he started feeding himself for the first time, his face looks like a Jackson Pollock by the end of it. But he gets it in, he feeds himself beautifully. I'm proud of him every day, because I just think he's magic.'
Colin also described watching his son take his first steps just before his fourth birthday.
Detailing the 'profound' moment to People, Colin said: 'I knew they [James's carers] were working on walking. And I stood over there, and she let him go, and he just came to [me].
He shares his younger son Henry with Ondine co-star, Polish actress Alicja Bachleda-Curus (pictured, in 2010) whom he dated from from approximately late 2008 to early 2010
'It was so profound. It was magic.
'I'll never forget just the face of determination on him as he walked toward me. He took, like, six steps, and I burst into tears.'
James's condition is severe enough that he is nonverbal and requires the help of a live-in caregiver to accomplish his day-to-day tasks.
When James was four, Colin went public with his Angelman Syndrome, saying his son had demonstrated 'amazing courage' in the face of his condition.
Shortly before James turned 18, Colin and Kim filed to obtain a conservatorship of him, noting he still needed help with tasks like getting dressed and making meals.
He later went on to reveal that he and James's mother make sure to share in the smallest victories and enjoy the milestones whatever age they happen - including James's first words aged six, being able to feed himself at 19, and getting his seizures under control.
Colin has maintained a very private life and has not spoken about his son in great detail until recently, although he told InStyle he first decided to 'talk publicly about the pride and joy I had in our son' while attending the 2007 Special Olympics.
He said: 'He has enriched my life, but I don't want to minimize the trials that so many families go through; the fear, consternation, frustration, and pain... When you're the parent of a child with special needs, it's important to feel that you're not alone.'
Discussing being a parent to a child with disabilities, the Hollywood star said that James was the main reason he was able to get sober.
Colin and James's mother Kim dated from 2001 to 2003. He later had Henry with his Ondine co-star Alicja, whom he dated from from approximately late 2008 to early 2010.
What is Angelman syndrome?
Angelman syndrome is a genetic condition that affects the nervous system and causes severe physical and learning disabilities.
A person with Angelman syndrome will have a near-normal life expectancy, but they will need support throughout their life.
Characteristics of Angelman syndrome
A child with Angelman syndrome will begin to show signs of delayed development at around six to 12 months of age, such as being unable to sit unsupported or make babbling noises.
Later, they may not speak at all, or may only be able to say a few words. However, most children with Angelman syndrome will be able to communicate using gestures, signs or other systems.
The movement of a child with Angelman syndrome will also be affected. They may have difficulty walking because of issues with balance and co-ordination (ataxia). Their arms may tremble or make jerky movements, and their legs may be stiff.
Several distinctive behaviours are associated with Angelman syndrome. These include:
* frequent laughter and smiling, often with little stimulus
* being easily excitable, often flapping the hands
* being restless (hyperactive)
* having a short attention span
* trouble sleeping and needing less sleep than other children

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Motorcyclist dies following crash in Dublin that killed garda
Motorcyclist dies following crash in Dublin that killed garda

BBC News

time24 minutes ago

  • BBC News

Motorcyclist dies following crash in Dublin that killed garda

The motorcyclist who was involved in a crash that saw a garda (Irish police) officer killed in Dublin last month, has died in man in his 30s died on Saturday in Beaumont hospital following the crash on May was riding a motorbike when he was involved in the crash in Lanestown, in the north of the county, shortly before 13:00 local time. Garda Kevin Flatley, 49, died at the scene after he was hit by the motorcyclist whilst carrying out a speed checkpoint. Garda Commissioner Drew Harris said he was deeply saddened by the death of his colleague and extended his sympathies to Mr Flatley's family and said it is providing support to both families involved.

Cáit Lynch thought Kerry days were over before return to panel after Covid-19
Cáit Lynch thought Kerry days were over before return to panel after Covid-19

BreakingNews.ie

time33 minutes ago

  • BreakingNews.ie

Cáit Lynch thought Kerry days were over before return to panel after Covid-19

Leaving for work in 2016, the dream for Kerry's Cáit Lynch to lift the Brendan Maher cup in Croke Park looked like it was gone, but her dream came true last August. The 32-year-old moved to the Netherlands in 2016 for work, having been captain of Kerry in 2015, the last time Lynch was captain before this season. Advertisement As the years went by, the Kerry woman's changes of returning for the kingdom were fading, as she was reduced to playing recreational Gaelic football in Amsterdam. However, after the Covid-19 pandemic, Lynch found herself back in Ireland, and soon back in a Kerry jersey. "I thought the county days had passed me until Covid happened. "'I had to make the decision to leave for work (in 2016) so it was a very big decision at the time. They put down a good few tough years as well when I was away, so I was lucky enough to come back when I did." Advertisement Lynch was key for Kerry last season as they won their first All-Ireland title since 1993 when they defeated Galway last August. Before August, there was final defeats to Dublin and Meath, as they had to dig deep to overcome heartbreak. "Every year, you have to believe that you can win. "The bigger the belief and the bigger the loss, the bigger the hurt as well. It was very tough to come back, but I suppose the motivation nearly grew every year as well. Especially in the two previous years where we'd gotten to finals, we knew we were so close. Advertisement "There were just a few little changes or small things that could be changed that we think, right, maybe this could be the year then. I do think, as tough as it is, the motivation does actually grow. "That's what kept us going for so long as well." Two competitions down so far this season, and Kerry have two pieces of silverware. The Kingdom defeated Armagh in the Division One final, and followed it up with another Munster championship with a victory over Waterford in the final last weekend. Advertisement Following the the retirement of Louise Ní Mhuircheartaigh, Lynch is now Kerry's longest serving player, as they search for back-to-back All-Ireland's for the first time since the 1980s. For the two-time all-star, Lynch is pleased Kerry have continued their success under new management and the loss of experienced players. "I suppose at the start of the year we had a lot of changes with players leaving, retiring or taking a year out, and we had a complete change to the management as well, so it's hard to know how the year will pan out. 'But we were lucky that a really strong core of the team had stayed and I think that really helped with the transition from last year. 'You just never know how a season is going to go. We were hoping that we'd do well in the league, I think initially we were trying not to get relegated and then anything after that is nearly a bonus. 'We were hoping to do well in the Munster championship as well. We've been delighted with how the season has gone so far.'

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

Reuters

time33 minutes ago

  • Reuters

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

CHICAGO, June 1 (Reuters) - Treating breast cancer patients with AstraZeneca's (AZN.L), opens new tab experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could change the way such cancers are treated, cancer experts said on Sunday. The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test called a liquid biopsy to indicate the need for a change in treatment in women with a common form of breast cancer, even before tumor growth can be detected on imaging. The early switch approach in women with hormone receptor-positive, HER2-negative breast cancer resulted in a 56% reduction in the risk of disease progression or death, said Dr. Eleonora Teplinsky, an oncologist at Valley-Mount Sinai Comprehensive Cancer Care and an ASCO breast cancer expert. "When patients progress on scans, we're already behind," Teplinsky said at a media briefing. She said an early switch approach, before disease progression, allows doctors "to essentially stay ahead of the curve." Camizestrant is not yet FDA-approved, but Teplinsky believes the data will likely result in a new treatment paradigm. The trial involved 3,256 patients with advanced hormone receptor-positive, HER2-negative breast cancer, the most common type in which hormones such as estrogen fuel cancer growth. These cancers lack high levels of HER2, another cancer driver. Women in the trial had at least six months of treatment with aromatase inhibitors that block hormones fueling the cancer, as well as targeted drugs called CDK4/6 inhibitors such as Novartis' (NOVN.S), opens new tab Kisqali, Pfizer's (PFE.N), opens new tab Ibrance or Lilly's (LLY.N), opens new tab Verzenio, which block an enzyme that fuels cancer growth. About 40% of patients treated with aromatase inhibitors develop mutations in the estrogen receptor 1 gene called ESR1 mutations, a sign of early drug resistance. Camizestrant and similar drugs called Selective Estrogen Receptor Degraders (SERDS) block estrogen receptor signaling in cancer cells. In the trial, researchers used blood tests to look for ESR1 mutations until 315 patients were identified. They were randomly assigned to either switch to camizestrant plus the CDK4/6 inhibitor (157 patients) or continue with standard treatment plus a placebo (158 patients). The researchers found that it took 16 months for the disease to progress in women who got camizestrant, compared with 9.2 months in those who continued on standard therapy, a statistically significant difference in progression-free survival. No new side effects were reported and few patients from either group dropped out due to side effects. "This is going to be very impactful for our patients," said Dr. Hope Rugo, head of breast medical oncology at City of Hope in Duarte, California. The question, she said, is how do doctors incorporate the testing into clinical practice. Separately, adding AstraZeneca's immunotherapy durvalumab to standard treatment before and after surgery in patients with early-stage stomach and esophageal cancers helped extend the time patients had without cancer progression or recurrence compared to chemotherapy alone. The global study of nearly 950 patients tested durvalumab, sold under the brand Imfinzi, in combination with a chemotherapy regimen called FLOT given around the time of initial cancer surgery. Patients in the durvalumab plus FLOT arm experienced a 29% better event-free survival than those who received the chemotherapy regimen. "We demonstrate that immunotherapy works in early-stage disease, which is great," lead study author Dr. Yelena Jarnigan of Memorial Sloan Kettering Cancer Center in New York told reporters at the meeting. "We did not see any new safety signals, so this will change practice for our patients, which is exciting to see." Both studies were published on Sunday in the New England Journal of Medicine.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store